- Home
- NXL vs SHFS Comparison
NXL vs SHFS Comparison
Compare NXL & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- SHFS
- Stock Information
- Founded
- NXL 2010
- SHFS 2015
- Country
- NXL United States
- SHFS United States
- Employees
- NXL N/A
- SHFS N/A
- Industry
- NXL Medical Specialities
- SHFS Finance: Consumer Services
- Sector
- NXL Health Care
- SHFS Finance
- Exchange
- NXL Nasdaq
- SHFS Nasdaq
- Market Cap
- NXL 24.2M
- SHFS 20.8M
- IPO Year
- NXL 2022
- SHFS N/A
- Fundamental
- Price
- NXL $1.19
- SHFS $2.78
- Analyst Decision
- NXL Strong Buy
- SHFS
- Analyst Count
- NXL 1
- SHFS 0
- Target Price
- NXL $5.00
- SHFS N/A
- AVG Volume (30 Days)
- NXL 126.6K
- SHFS 26.5K
- Earning Date
- NXL 05-13-2025
- SHFS 05-21-2025
- Dividend Yield
- NXL N/A
- SHFS N/A
- EPS Growth
- NXL N/A
- SHFS N/A
- EPS
- NXL N/A
- SHFS N/A
- Revenue
- NXL $131,065.00
- SHFS $13,956,453.00
- Revenue This Year
- NXL $79.59
- SHFS N/A
- Revenue Next Year
- NXL $334.65
- SHFS N/A
- P/E Ratio
- NXL N/A
- SHFS N/A
- Revenue Growth
- NXL N/A
- SHFS N/A
- 52 Week Low
- NXL $0.53
- SHFS $1.84
- 52 Week High
- NXL $4.49
- SHFS $15.20
- Technical
- Relative Strength Index (RSI)
- NXL 30.13
- SHFS 50.65
- Support Level
- NXL $1.18
- SHFS $2.25
- Resistance Level
- NXL $1.24
- SHFS $2.83
- Average True Range (ATR)
- NXL 0.07
- SHFS 0.27
- MACD
- NXL 0.02
- SHFS 0.12
- Stochastic Oscillator
- NXL 18.18
- SHFS 94.62
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.